Stocks and Investing Stocks and Investing
Tue, November 1, 2022

Esther Hong Initiated (ACAD) at Hold and Held Target at $17 on, Nov 1st, 2022


Published on 2024-10-27 23:47:40 - WOPRAI, Esther Hong
  Print publication without navigation


Esther Hong of Loop Capital, Initiated "ACADIA Pharmaceuticals Inc." (ACAD) at Hold and Held Target at $17 on, Nov 1st, 2022.

Esther has made no other calls on ACAD in the last 4 months.



There are 8 other peers that have a rating on ACAD. Out of the 8 peers that are also analyzing ACAD, 4 agree with Esther's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Salveen Richter of "Goldman Sachs" Maintained at Hold with Decreased Target to $15 on, Wednesday, August 10th, 2022
  • Vamil Divan of "Mizuho" Maintained at Hold with Decreased Target to $19 on, Wednesday, August 10th, 2022
  • Jeffrey Hung of "Morgan Stanley" Maintained at Hold with Decreased Target to $18 on, Tuesday, August 9th, 2022
  • Neena Bitritto-Garg of "Citigroup" Downgraded from Strong Buy to Hold and Decreased Target to $15 on, Monday, August 8th, 2022


These are the ratings of the 4 analyists that currently disagree with Esther


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $25 on, Tuesday, August 9th, 2022
  • Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $21 on, Tuesday, August 9th, 2022
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $21 on, Tuesday, August 9th, 2022
  • Ritu Baral of "Cowen & Co." Maintained at Buy with Decreased Target to $21 on, Monday, August 8th, 2022
Contributing Sources